These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195 [TBL] [Abstract][Full Text] [Related]
3. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice. Dam TN; Kang S; Nickoloff BJ; Voorhees JJ J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756 [TBL] [Abstract][Full Text] [Related]
4. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Nickoloff BJ; Wrone-Smith T Am J Pathol; 1999 Jul; 155(1):145-58. PubMed ID: 10393847 [TBL] [Abstract][Full Text] [Related]
5. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis. Nickoloff BJ J Investig Dermatol Symp Proc; 2000 Dec; 5(1):67-73. PubMed ID: 11147678 [TBL] [Abstract][Full Text] [Related]
6. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions. de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323 [TBL] [Abstract][Full Text] [Related]
7. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. Gilhar A; Ullmann Y; Kerner H; Assy B; Shalaginov R; Serafimovich S; Kalish RS J Invest Dermatol; 2002 Aug; 119(2):384-91. PubMed ID: 12190861 [TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. Gilhar A; David M; Ullmann Y; Berkutski T; Kalish RS J Invest Dermatol; 1997 Sep; 109(3):283-8. PubMed ID: 9284091 [TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913 [TBL] [Abstract][Full Text] [Related]
10. The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model. Nickoloff BJ Cutis; 2000 Feb; 65(2):110-4. PubMed ID: 10696565 [TBL] [Abstract][Full Text] [Related]
11. Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model. Nickoloff BJ; Kunkel SL; Burdick M; Strieter RM Am J Pathol; 1995 Mar; 146(3):580-8. PubMed ID: 7887440 [TBL] [Abstract][Full Text] [Related]
12. The role of immune system in the pathogenesis of psoriasis. Baadsgaard O; Fisher G; Voorhees JJ; Cooper KD J Invest Dermatol; 1990 Nov; 95(5 Suppl):32S-34S. PubMed ID: 16788627 [TBL] [Abstract][Full Text] [Related]
13. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Nickoloff BJ; Mitra RS; Elder JT; Fisher GJ; Voorhees JJ Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168 [TBL] [Abstract][Full Text] [Related]
14. Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes? Komine M; Karakawa M; Takekoshi T; Sakurai N; Minatani Y; Mitsui H; Tada Y; Saeki H; Asahina A; Tamaki K J Invest Dermatol; 2007 Aug; 127(8):1915-22. PubMed ID: 17446902 [TBL] [Abstract][Full Text] [Related]
15. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117 [TBL] [Abstract][Full Text] [Related]
16. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. Nestle FO; Turka LA; Nickoloff BJ J Clin Invest; 1994 Jul; 94(1):202-9. PubMed ID: 8040262 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. Nickoloff BJ; Bonish B; Huang BB; Porcelli SA J Dermatol Sci; 2000 Dec; 24(3):212-25. PubMed ID: 11084303 [TBL] [Abstract][Full Text] [Related]
18. Xenotransplantation Model of Psoriasis. Di Domizio J; Conrad C; Gilliet M Methods Mol Biol; 2017; 1559():83-90. PubMed ID: 28063039 [TBL] [Abstract][Full Text] [Related]
19. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A. Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064 [TBL] [Abstract][Full Text] [Related]
20. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Paukkonen K; Naukkarinen A; Horsmanheimo M Arch Dermatol Res; 1995; 287(2):165-70. PubMed ID: 7763088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]